Session » Epidemiology and Public Health - Poster II

Date: Monday, November 14, 2016

Time: 9:00AM-11:00AM

Meeting: 2016 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 1169

A Systematic Review of Rheumatic Disease Epidemiology in the Indigenous Populations of Canada, the United States, Australia and New Zealand

9:00AM-11:00AM: Abstract Number: 1196

AA Amyloidosis: An Evaluation of Epidemiology and Prevalence in the US and EU5 Countries

9:00AM-11:00AM: Abstract Number: 1172

Azathioprine and Mycophenolate Mofetil Adherence in a Nationwide Medicaid Cohort with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1180

Class V Lupus Nephritis Results in Significant Numbers of End Stage Renal Disease and Death in a Population-Based Registry

9:00AM-11:00AM: Abstract Number: 1190

Incidence and Prevalence of Polymyalgia Rheumatic and Giant Cell Arteritis: A 15-Year Study in a Health Care Management Organization

9:00AM-11:00AM: Abstract Number: 1167

Incidence of Primary Chronic Cutaneous Lupus Erythematosus in a Metropolitan Area of the Southeastern United States: The Georgia Lupus Registry

9:00AM-11:00AM: Abstract Number: 1185

Increased Risk of Osteoporotic Fractures in Patients with Primary SjöGren Syndrome: A Nationwide Population-Based Study in Taiwan

9:00AM-11:00AM: Abstract Number: 1189

Inpatient Trends for Adults with Scleroderma in the United States: A 20 Year Analysis

9:00AM-11:00AM: Abstract Number: 1178

Is Subclinical Atherosclerosis Prevalent in a French Patient Cohort with Systemic Lupus Erythematosus?

9:00AM-11:00AM: Abstract Number: 1183

Lack of Awareness of Sexual Health in Rheumatology. High Prevalence of Sexual Dysfunction Among Women with Rheumatic Diseases

9:00AM-11:00AM: Abstract Number: 1194

Low Body Mass Index and Smoking Are Associated with a Lower Risk of Sarcoidosis: A Population-Based Nested Case-Control Study

9:00AM-11:00AM: Abstract Number: 1188

Major Comorbidities of Idiopathic Inflammatory Myositis: A Population-Based Study Using 10 Years of Follow up from the National Health Insurance in Korea

9:00AM-11:00AM: Abstract Number: 1170

Month of Birth Affects the Risk of Rheumatic Diseases: A Nationwide Case-Control Study

9:00AM-11:00AM: Abstract Number: 1192

Mortality and Survival of Patients Diagnosed with GCA in Bergen (Western Norway) 1972-2012

9:00AM-11:00AM: Abstract Number: 1193

Mortality Rate According to Cause in Patients with Hemophagocytic Lymphohistiocytosis: A Meta-Analysis

9:00AM-11:00AM: Abstract Number: 1171

Obesity and the Risk of Systemic Lupus Erythematosus in the Nurses’ Health Studies

9:00AM-11:00AM: Abstract Number: 1182

Opiod Use and Death in Chronic Pain Patients with Systemic Lupus Erythematosis

9:00AM-11:00AM: Abstract Number: 1174

Perceived Stress and Reported Cognitive Symptoms Among Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1177

Pneumocystis Jirovecii Pneumonia in Systemic Autoimmune Inflammatory Diseases

9:00AM-11:00AM: Abstract Number: 1176

Prevalence of Influenza and Pneumococcal Polysaccharide Vaccine Administration and the Factors Affecting Vaccine Uptake in a Population of Patients with Autoimmune Inflammatory Rheumatic Diseases in a Brooklyn Clinic

9:00AM-11:00AM: Abstract Number: 1184

Projected 2015 Prevalence of Physician-Diagnosed Primary SjöGren’s Syndrome Based on 1976-2005 Annual Incidence Rates in a Well-Defined U.S. Population

9:00AM-11:00AM: Abstract Number: 1191

Retinal Vessel Morphometry Associations with Polymyalgia Rheumatica; Findings from the European Prospective Investigation of Cancer (EPIC) in Norfolk

9:00AM-11:00AM: Abstract Number: 1181

Risk Factors for Incident Fractures in Patients with Systemic Lupus Erythematosus on Dialysis

9:00AM-11:00AM: Abstract Number: 1195

Risk of Hospitalized Infection Among Patients with Sarcoidosis: A Population-Based Retrospective Cohort Study

9:00AM-11:00AM: Abstract Number: 1173

Screening for Depression and Anxiety in an Outpatient Rheumatology Clinic Using Validated Self-Applied Questionnaires

9:00AM-11:00AM: Abstract Number: 1168

The Epidemiology of Individuals Not Fully Meeting Classification Criteria for Systemic Lupus Erythematosus (SLE): The Georgia Lupus Registry

9:00AM-11:00AM: Abstract Number: 1179

The Impact of Autoimmune Disease in the Management and Prognosis of Acute Coronary Syndrome

9:00AM-11:00AM: Abstract Number: 1186

The Use of Clinical Mucosal Manifestations to Differentiate Patients with Lupus and Dermatomyositis: Transversal, Retrospective and Analytical Study of 116 Patients

9:00AM-11:00AM: Abstract Number: 1175

Thirty Day Readmission Rates for Patients Diagnosed with Systemic Lupus Erythematosus: Analysis at a Tertiary Care Center

9:00AM-11:00AM: Abstract Number: 1187

Ultraviolet Radiation Exposures Are Associated with Dermatomyositis in a National Myositis Registry

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].